全球乳鐵蛋白市場規模（按功能、應用、區域範圍和預測）

乳鐵蛋白市場規模及預測

預計 2024 年乳鐵蛋白市場規模將達到 20.6 億美元，到 2032 年將達到 44.9 億美元，2026 年至 2032 年的複合年成長率為 7.9%。

消費者對健康和飲食的意識不斷增強，以及皮膚相關健康問題發病率的上升，被認為是推動需求成長的因素。乳鐵蛋白被認為具有抗病毒、抗菌、抗寄生蟲、催化和抗過敏的活性和特性，這可能會刺激該產品在醫藥和個人護理領域的需求。根據美國皮膚病學會的數據，痤瘡是美國最常見的皮膚問題，每年影響 4,000 萬至 5,000 萬人。全球乳鐵蛋白市場報告對市場進行了全面的評估。它對關鍵細分市場、趨勢、市場促進因素、限制因素、競爭格局以及在市場中發揮關鍵作用的因素進行了全面的分析。

定義全球乳鐵蛋白市場

乳鐵蛋白是一種源自牛奶的膳食補充品。它從牛中提取，並被配製成各種商業食品，包括個人護理用品、嬰兒奶粉、牙膏和膳食補充劑。這種多功能蛋白質會根據溫度、物理和化學條件發生構象變化。為了避免變性，需要增強和最佳化粗乳鐵蛋白萃取物和含乳鐵蛋白食品的加工過程。

它對改善胃潰瘍、腸潰瘍、腹瀉和丙型肝炎尤其有效。它也能作為抗氧化劑，預防細菌和病毒性疾病。它對人體有多種健康益處，包括防止組織損傷、預防癌症和激活免疫反應。食用乳鐵蛋白安全，但過量攝取可能會產生副作用。它在商店和網上很容易買到，通常以粉末形式出售。乳鐵蛋白具有抗病毒、抗菌、抗致癌和抗發炎特性。這種蛋白質的抗菌和抗真菌特性主要作為人體的防禦機制。乳鐵蛋白具有抗菌和抗真菌特性，適合人類新生兒。

全球乳鐵蛋白市場概覽

痤瘡在美國、加拿大和德國等已開發國家日益普遍，而關於使用乳鐵蛋白治療痤瘡的可靠推薦和研究結果可能會在整個預測期內為產品製造商帶來成長機會。全球個人保健部門規模達數十億美元，正從傳統的實體店業務轉向利基市場和網路零售商。所有年齡層的女性都更喜歡跨管道購買，她們會先訪問在線門戶網站了解產品資訊，然後再從線下零售商處購買。

品牌商的行銷活動提升了消費者的認知度，加上消費者對副作用更小、功效更高的有機產品的偏好，預計將進一步推動該產品的需求。乳鐵蛋白廣泛用於降低皮膚免疫反應，並透過活化表皮細胞結締組織和重建皮膚來促進創傷治療。其抗炎特性有助於防止更大的粉刺和囊腫的形成。多項臨床研究表明，乳鐵蛋白有助於治療和預防胃腸道發炎疾病。

消費者對腸道健康的認知不斷提升，以及對預防腸躁症和腹脹以及減輕腸道發炎產品的需求不斷成長，預計將在整個預測期內推動乳鐵蛋白市場的擴張。然而，與乳鐵蛋白使用相關的不良反應（例如腹瀉）預計將對乳鐵蛋白市場的擴張構成重大障礙。乳鐵蛋白的高價格預計將進一步阻礙市場擴張。政府推廣母乳哺育的措施也預計將減緩乳鐵蛋白市場的成長率。

目錄

第1章全球乳鐵蛋白市場介紹

• 市場概覽
• 研究範圍
• 先決條件

第2章執行摘要

第3章：已驗證的市場研究調查方法

• 資料探勘
• 驗證
• 第一手資料
• 資料來源列表

第4章全球乳鐵蛋白市場展望

• 概述
• 市場動態
  • 驅動程式
  • 限制因素
  • 機會
• 波特五力模型
• 價值鏈分析

第5章全球乳鐵蛋白市場（依功能）

• 概述
• 鐵的吸收
• 消炎（藥）
• 保護腸內菌叢
• 抗菌
• 免疫細胞刺激
• 抗氧化作用

第6章 全球乳鐵蛋白市場應用

• 概述
• 飲食
• 嬰兒奶粉
• 運動機能性食品
• 製藥
• 個人保健產品
• 餵食

第7章全球乳鐵蛋白市場（按地區）

• 概述
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 法國
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 其他亞太地區
• 其他
  • 拉丁美洲
  • 中東和非洲

第8章全球乳鐵蛋白市場競爭格局

• 概述
• 各公司市場排名
• 重點發展策略

第9章 公司簡介

• InVitria
• Hilmar Cheese Company
• Glanbia plc
• Pharming Group NV
• APS BioGroup
• FrieslandCamina
• Synlait Milk Ltd.
• Ferrin-tech LLC
• Ingredia SA
• Tatura Milk Industries Ltd.

第10章 附錄

• 相關調查

Lactoferrin Market Size And Forecast

Lactoferrin Market size was valued at USD 2.06 Billion in 2024 and is projected to reach USD 4.49 Billion by 2032, growing at a CAGR of 7.9% from 2026 to 2032.

The increased consumer awareness of health and diet, as well as the rising occurrence of skin-related health issues, are likely to drive demand. Lactoferrin is thought to offer antiviral, antibacterial, antiparasitic, catalytic, and anti-allergic activities and qualities, which will increase product demand in the pharmaceutical and personal care sectors. Acne is the most common skin problem in the United States, impacting 40 to 50 million individuals each year, according to the American Academy of Dermatology. The Global Lactoferrin Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Lactoferrin Market Definition

Lactoferrin is a nutritional supplement derived from milk. Lactoferrin is extracted from bovine milk and then mixed into a variety of commercial food products, including personal care items, infant formula, toothpaste, and nutraceuticals. Temperature, as well as physical and chemical restrictions, can trigger conformational changes in this multi-function protein. To avoid denaturation, the lactoferrin crude extract and process factors for lactoferrin-containing food items should be enhanced and optimized.

Among other things, it can assist with stomach and intestinal ulcers, diarrhea, and hepatitis C. It also acts as an antioxidant, which protects against bacterial and viral illnesses. It provides several health advantages for the body, including tissue damage prevention, cancer prevention, immune response activation, and other benefits. It is safe to consume, but excessive doses might have negative consequences. It is readily accessible in stores and online. It is most often found as a powder. Lactoferrin has antiviral, antibacterial, anti-carcinogenic, and anti-inflammatory properties. The protein's antibacterial and antifungal activities serve largely as a defense mechanism in the body. Lactoferrin is antibacterial and antifungal, making it suitable for human newborns.

Global Lactoferrin Market Overview

Acne is becoming more common in developed countries such as the United States, Canada, and Germany, and confirmed testimonies and study findings for lactoferrin-induced acne therapy are likely to drive growth opportunities for product producers throughout the projection period. The worldwide personal care sector is worth billions of dollars and is shifting away from traditional brick-and-mortar businesses and towards niche and internet retailers. Women of all ages prefer a cross-channel purchase method, where they visit online portals to learn about the goods before purchasing from an offline retail location.

Consumer awareness as a result of brand owners' product marketing operations, along with a preference for organic products with fewer side effects and improved efficiency, is predicted to boost product demand even further. Lactoferrin is widely used in the reduction of dermal immune response and wound healing by activating connective tissue with epidermal cells and rebuilding the skin. Its anti-inflammatory properties help to prevent the production of bigger zits and cysts. Lactoferrin has been shown in several clinical trials to be useful in the treatment and prevention of gastrointestinal inflammatory diseases.

Rising consumer knowledge about gut health, along with rising product demand to avoid irritable bowel movement and bloating, as well as to reduce intestinal inflammation, is expected to drive the expansion of the Lactoferrin Market throughout the projected period. However, negative effects associated with lactoferrin use, such as diarrhea, will pose a significant hurdle to the expansion of the Lactoferrin Market. The high prices connected with lactoferrin will further stymie market expansion. Increased government attempts to promote breastfeeding will also slow the growth rate of the Lactoferrin Market.

Global Lactoferrin Market: Segmentation Analysis

The Global Lactoferrin Market is Segmented Based on Function, Application, And Geography.

Lactoferrin Market, By Function

• Iron Absorption
• Anti-Inflammatory
• Intestinal Flora Protection
• Antibacterial
• Immune Cell Stimulation
• Antioxidant

Based on Function, the market is segmented into Iron Absorption, Anti-Inflammatory, Intestinal Flora Protection, Antibacterial, Immune Cell Stimulation, and Antioxidant. The iron absorption segment generated the most revenue in 2022 and is predicted to continue its lead throughout the projection period. Iron deficiency frequently results in anemia, which affects around 30% of the world's population. Lactoferrin has been a critical remedy for anemia because of its high bioavailability and capacity to enhance serum ferritin levels by five times when compared to other iron sources. According to the WHO, anemia affects about 1.62 billion people worldwide, with pre-school-aged children having the highest incidence, accounting for 47.4% of the total afflicted population.

Lactoferrin Market, By Application

• Food & Beverages
• Infant Formula
• Sports & Functional Foods
• Pharmaceuticals
• Personal Care Products
• Animal Feed

Based on Application, the market is segmented into Food & Beverages, Infant Formula, Sports & Functional Foods, Pharmaceuticals, Personal Care Products, and Animal Feed. In 2022, the baby formula category led the Lactoferrin Market, accounting for the biggest revenue share. From 2023 to 2030, the category is predicted to grow at a stable CAGR. The increased number of clinical studies supporting baby formula integration with lactoferrin, as well as changing consumer dynamics towards newborn supplemental meals, are expected to drive demand. The demand for newborn nourishment is primarily from developed economies, owing to high disposable money, hectic work schedules, and increased rates of iron deficiency in newborns.

Lactoferrin Market, By Geography

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Based on Regional Analysis, the Lactoferrin Market is classified into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. In 2022, Asia Pacific will be the largest regional market. Throughout the projection period, the regional market is likely to maintain its position. The regional market expansion, led by India, China, and Japan, may be attributable to increased population and consumer purchasing capacity. Unlike most other areas, Asia Pacific contains a substantial number of middle and small firms.

• Furthermore, increased consumer knowledge about newborn nutrition, personal care, and pharmaceutical goods, as well as consumer preference for organic products, are likely to boost the market for lactoferrin in the area. In 2022, North America was the second-largest geographic market for lactoferrin. The United States has emerged as the region's largest market. The rising prevalence of digestive problems has increased product demand across the country.

Key Players

The "Global Lactoferrin Market" study report will provide valuable insight with an emphasis on the global market including some of the major players such as InVitria, Hilmar Cheese Company, Glanbia plc, Pharming Group NV, APS BioGroup, FrieslandCamina, Synlait Milk Ltd., Ferrin-tech LLC, Ingredia SA, MP Biomedicals, Tatura Milk Industries Ltd., ProHealth, Fonterra Cooperative Group Ltd., Farbest Brands, Milei GmbH.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• In April 2022, Before it can be licensed for sale on the market, leniolisib, a possible therapy for activated phosphoinositide 3-kinase delta syndrome (APDS) in children, must first go through the regulatory procedure of having an agreed-upon Paediatric Investigation Plan (PIP). Leniolisib has been designated as a Promising Innovative Medicine (PIM), indicating that it may be eligible for the MHRA's Early Access to Medicines Scheme.
• In May 2021, Laura Kelly, Governor of Kansas, and Hilmar Cheese Company, Inc. officials announced that the company has opted to build a brand new, cutting-edge cheese and whey protein production plant in Dodge City, Kansas.
• In September 2020, FrieslandCampina WAMCO completed the acquisition of Nuticima's dairy business. This acquisition has improved Friesl and Campina's production capacity, allowing them to meet the rising demand in Nigeria for powder milk and evaporated milk.
• In October 2020, Milei GmbH reported an increase in lactoferrin manufacturing capacity to 170 tonnes, more than doubling the capacity in 2019. The net investment will be USD 18.3 million.
• In September 2020, FrieslandCampina Ingredients said that it would boost its lactoferrin production capacity in Veghel, Netherlands, by 60 metric tonnes by 2022. This will aid the company's strategic growth in the Early Life Nutrition and Adult Nutrition areas. FrieslandCampina Ingredients will be the world's largest manufacturer of lactoferrin, with a new capacity of 70 mt per year.
• Ace Matrix Analysis
• The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories as Active, Cutting Edge, Emerging, and Innovators.
• Market Attractiveness
• The image of market attractiveness provided would further help to get information about the region that is majorly leading in the Global Lactoferrin Market. We cover the major impacting factors that are responsible for driving the industry growth in the given region.
• Porter's Five Forces
• The image provided would further help to get information about Porter's five forces framework providing a blueprint for understanding the behavior of competitors and a player's strategic positioning in the respective industry. Porter's five forces model can be used to assess the competitive landscape in the Global Lactoferrin Market gauge the attractiveness of a certain sector, and assess investment possibilities.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL LACTOFERRIN MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL LACTOFERRIN MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL LACTOFERRIN MARKET, BY FUNCTION

• 5.1 Overview
• 5.2 Iron Absorption
• 5.3 Anti-Inflammatory
• 5.4 Intestinal Flora Protection
• 5.5 Antibacterial
• 5.6 Immune Cell Stimulation
• 5.7 Antioxidant

6 GLOBAL LACTOFERRIN MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 Food & Beverages
• 6.3 Infant Formula
• 6.4 Sports & Functional Foods
• 6.5 Pharmaceuticals
• 6.6 Personal Care Products
• 6.7 Animal Feed

7 GLOBAL LACTOFERRIN MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Rest of the World
  • 7.5.1 Latin America
  • 7.5.2 Middle East & Africa

8 GLOBAL LACTOFERRIN MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
• 8.3 Key Development Strategies

9 COMPANY PROFILES

• 9.1 InVitria
  • 9.1.1 Overview
  • 9.1.2 Financial Performance
  • 9.1.3 Product Outlook
  • 9.1.4 Key Developments
• 9.2 Hilmar Cheese Company
  • 9.2.1 Overview
  • 9.2.2 Financial Performance
  • 9.2.3 Product Outlook
  • 9.2.4 Key Developments
• 9.3 Glanbia plc
  • 9.3.1 Overview
  • 9.3.2 Financial Performance
  • 9.3.3 Product Outlook
  • 9.3.4 Key Developments
• 9.4 Pharming Group NV
  • 9.4.1 Overview
  • 9.4.2 Financial Performance
  • 9.4.3 Product Outlook
  • 9.4.4 Key Developments
• 9.5 APS BioGroup
  • 9.5.1 Overview
  • 9.5.2 Financial Performance
  • 9.5.3 Product Outlook
  • 9.5.4 Key Developments
• 9.6 FrieslandCamina
  • 9.6.1 Overview
  • 9.6.2 Financial Performance
  • 9.6.3 Product Outlook
  • 9.6.4 Key Developments
• 9.7 Synlait Milk Ltd.
  • 9.7.1 Overview
  • 9.7.2 Financial Performance
  • 9.7.3 Product Outlook
  • 9.7.4 Key Developments
• 9.8 Ferrin-tech LLC
  • 9.8.1 Overview
  • 9.8.2 Financial Performance
  • 9.8.3 Product Outlook
  • 9.8.4 Key Developments
• 9.9 Ingredia SA
  • 9.9.1 Overview
  • 9.9.2 Financial Performance
  • 9.9.3 Product Outlook
  • 9.9.4 Key Developments
• 9.10 Tatura Milk Industries Ltd.
  • 9.10.1 Overview
  • 9.10.2 Financial Performance
  • 9.10.3 Product Outlook
  • 9.10.4 Key Developments

10 Appendix

• 10.1 Related Research